Cahaba Wealth Management Inc. Purchases 25 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cahaba Wealth Management Inc. increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,884 shares of the healthcare conglomerate’s stock after acquiring an additional 25 shares during the quarter. Cahaba Wealth Management Inc.’s holdings in UnitedHealth Group were worth $1,469,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bell Investment Advisors Inc boosted its stake in UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after purchasing an additional 24 shares in the last quarter. Harbor Investment Advisory LLC increased its position in shares of UnitedHealth Group by 3.2% during the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after acquiring an additional 1,129 shares in the last quarter. Austin Private Wealth LLC lifted its position in UnitedHealth Group by 9.8% in the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after acquiring an additional 111 shares in the last quarter. Vanguard Personalized Indexing Management LLC increased its holdings in shares of UnitedHealth Group by 7.9% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock worth $39,802,000 after purchasing an additional 5,537 shares in the last quarter. Finally, Capital Insight Partners LLC lifted its holdings in shares of UnitedHealth Group by 3.8% during the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on UNH. Truist Financial upped their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Robert W. Baird lifted their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. TD Cowen raised their price target on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Barclays increased their target price on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Wells Fargo & Company increased their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Trading Up 0.4 %

Shares of UNH stock opened at $597.64 on Friday. The stock has a fifty day simple moving average of $558.98 and a two-hundred day simple moving average of $515.15. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94. The firm has a market capitalization of $551.87 billion, a PE ratio of 36.53, a PEG ratio of 1.68 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.14 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is 51.34%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.